GO:0070538 oleic acid binding: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0070538 (oleic acid binding) is a molecular_function term describing binding to oleic acid, the 18-carbon monounsaturated fatty acid (9Z)-octadec-9-enoic acid.
Oleic acid binding proteins include intracellular lipid chaperones such as FABP4 and FABP5, membrane receptors, serum albumin, and odorant-binding proteins.
Oleic acid binding regulates lipid accumulation, apoptosis, mitochondrial function, and metabolic signaling in hepatocytes and other cell types.
Dysregulated oleic acid binding is linked to colorectal cancer progression, metabolic syndrome-associated endometrial cancer, and cardiac mitochondrial dysfunction.
Experimental approaches to study oleic acid binding include isothermal titration calorimetry, fluorescence spectroscopy, and lipidomics.
CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of oleic acid binding proteins in disease biology.

Description

Oleic acid binding (GO:0070538) is a molecular function defined as binding to oleic acid, the 18-carbon monounsaturated fatty acid (9Z)-octadec-9-enoic acid. This term captures the physical interaction between a protein or macromolecule and oleic acid, a central fatty acid in human metabolism and disease. Oleic acid is the most abundant monounsaturated fatty acid in many tissues and serves both as a metabolic substrate and as a signaling molecule. Proteins that bind oleic acid participate in lipid transport, metabolic regulation, and cellular stress responses. The importance of oleic acid binding extends across physiology and pathology. In hepatocytes, oleic acid binding influences lipid accumulation and apoptosis, with differential effects compared to saturated fatty acids such as palmitic acid. In the heart, oleic acid binding to adrenaline ameliorates adrenaline-induced mitochondrial dysfunction, revealing a direct molecular interaction with signaling molecules. In cancer, oleic acid-mediated metabolic reprogramming promotes polyamine accumulation in endometrial cancer under metabolic syndrome conditions, and plasma metabolomics identifies oleic acid as a functional metabolite in adenoma-colorectal cancer progression. For researchers, GO:0070538 provides a precise annotation for proteins that directly interact with oleic acid. Understanding these interactions requires integrating structural biology, lipid biochemistry, and functional genomics. This article reviews the definition, mechanisms, key genes, disease relevance, and research methods for studying oleic acid binding, with a focus on CRISPR-based models for causal validation.

oleic acid binding At A Glance

GO ID GO:0070538
GO term oleic acid binding
Ontology molecular_function
Synonym (none)
Definition Binding to oleic acid, the 18-carbon monounsaturated fatty acid (9Z)-octadec-9-enoic acid.
Major function Non-covalent interaction with oleic acid, enabling lipid sensing, transport, and metabolic regulation.
Representative proteins FABP4, FABP5, serum albumin, odorant-binding proteins, and other lipid-binding proteins.
Disease relevance Colorectal cancer, endometrial cancer, metabolic syndrome, cardiac mitochondrial dysfunction.
Research methods Isothermal titration calorimetry, fluorescence spectroscopy, lipidomics, and CRISPR screens.

What Is GO:0070538?

GO:0070538 (oleic acid binding) is a Gene Ontology molecular_function term defined as binding to oleic acid, the 18-carbon monounsaturated fatty acid (9Z)-octadec-9-enoic acid. In practical terms, it describes the selective, non-covalent interaction between a protein or macromolecular complex and oleic acid. This binding can be reversible and may involve hydrophobic pockets, lipid-binding domains, or electrostatic interactions. The term does not imply catalysis or transport per se, but rather the physical association with oleic acid as a ligand.

Why Is oleic acid binding Important in Cell Biology?

Oleic acid binding is important because oleic acid is a central monounsaturated fatty acid in human metabolism, and its interactions with proteins influence lipid storage, apoptosis, mitochondrial function, and cancer progression. The GO term GO:0070538 provides a standardized annotation for these interactions, enabling researchers to identify and compare oleic acid-binding proteins across species and experimental systems. Dysregulation of oleic acid binding has been implicated in metabolic syndrome, colorectal cancer, and endometrial cancer, making it a target for mechanistic studies and therapeutic development.
Oleic acid binding regulates lipid accumulation and apoptosis in hepatocytes, with effects distinct from saturated fatty acids.
Oleic acid binding to adrenaline protects against adrenaline-induced cardiac mitochondrial dysfunction.
Oleic acid-mediated polyamine accumulation promotes endometrial cancer under metabolic syndrome conditions.
Plasma and fecal metabolomics identify oleic acid as a functional metabolite in adenoma-colorectal cancer progression.
Serum albumin is a primary non-covalent binding protein for nitro-oleic acid, a nitrated derivative of oleic acid.
Odorant-binding proteins bind oleic acid to trigger behavioral responses in termites, showing evolutionary conservation of oleic acid binding.
Oleic acid treatment of rice grains reduces starch digestibility through starch-lipid complex formation, relevant to food science.
Interactive multiple binding of oleic acid with human serum albumin can be modulated by drugs such as warfarin and ibuprofen.
Oleic acid binding is a druggable interface for modulating lipid signaling and metabolic pathways.
CRISPR-based models enable causal testing of oleic acid binding proteins in disease contexts.

What Happens During oleic acid binding?

Oleic acid recognition and initial contact
In simple terms: The protein first recognizes and grabs onto oleic acid.
Oleic acid binding begins with the recognition of the fatty acid by a specific binding pocket or surface region on the target protein. This interaction is driven by hydrophobic and van der Waals forces, as oleic acid is a long-chain fatty acid with a cis double bond at position 9. For example, odorant-binding proteins in termites bind oleic acid to trigger burial behavior, demonstrating a specific recognition event. Serum albumin also binds oleic acid non-covalently, with multiple binding sites that can accommodate other ligands.
Conformational changes and complex stabilization
In simple terms: Once bound, the protein may change shape to hold oleic acid tightly.
Upon binding, the protein may undergo conformational changes that stabilize the oleic acid-protein complex. Isothermal titration calorimetry studies of oleic acid binding to adrenaline and heart mitochondria show that binding is associated with specific thermodynamic signatures, indicating structural rearrangements. In hepatocytes, oleic acid binding leads to differential lipid accumulation compared to palmitic acid, suggesting that the binding event triggers distinct downstream responses.
Downstream signaling and metabolic effects
In simple terms: The binding event sends signals or changes metabolism inside the cell.
Oleic acid binding can initiate signaling cascades or alter metabolic flux. In endometrial cancer, oleic acid-mediated polyamine accumulation promotes tumor growth under metabolic syndrome conditions, linking oleic acid binding to oncogenic metabolism. In colorectal cancer progression, oleic acid is identified as a functional metabolite, suggesting that its binding to cellular targets contributes to adenoma-carcinoma progression. In the heart, oleic acid binding to adrenaline ameliorates mitochondrial dysfunction, indicating a protective signaling role.
Regulation of oleic acid availability and binding
In simple terms: The amount of oleic acid and the proteins that bind it are controlled by the cell.
The availability of oleic acid for binding is regulated by lipid metabolism, including synthesis, uptake, and oxidation. Oleic acid treatment of rice grains reduces starch digestibility through formation of starch-lipid complexes, showing that oleic acid binding to macromolecules can alter their properties. In human serum, albumin acts as a primary non-covalent binding protein for nitro-oleic acid, and the presence of drugs such as warfarin and ibuprofen can modulate this binding. These examples illustrate that oleic acid binding is subject to competitive and environmental regulation.

Key Genes Involved in GO:0070538 oleic acid binding

The following genes and proteins are representative of oleic acid binding activity, based on published literature and functional annotations.
GeneMajor RoleResearch Relevance
FABP4Intracellular fatty acid chaperone that binds oleic acidMetabolic syndrome, cancer, lipid trafficking
FABP5Binds oleic acid and other fatty acidsLipid signaling, cancer progression
ALBSerum albumin binds oleic acid non-covalentlyDrug interactions, nitro-oleic acid transport
OBPOdorant-binding protein binds oleic acid in termitesBehavioral studies, evolutionary conservation
CD36Membrane receptor for fatty acids including oleic acidLipid uptake, metabolic disease
PPARGNuclear receptor activated by fatty acidsAdipogenesis, insulin sensitivity
SCD1Desaturase that synthesizes oleic acid from stearic acidLipid metabolism, cancer
DGAT1Enzyme that esterifies oleic acid into triglyceridesLipid storage, hepatosteatosis
CPT1AMitochondrial enzyme that binds oleic acid derivativesFatty acid oxidation, cardiac function
HSPA8Chaperone that interacts with oleic acidProtein folding, lipid stress
LPLLipoprotein lipase binds and hydrolyzes oleic acid estersLipid processing, atherosclerosis
FABP1Liver fatty acid-binding protein binds oleic acidHepatic lipid metabolism
FABP3Heart-type fatty acid-binding protein binds oleic acidCardiac mitochondrial function
SLC27A1Fatty acid transport protein that facilitates oleic acid uptakeMetabolic disorders
ACSL1Acyl-CoA synthetase that activates oleic acidLipid synthesis, energy metabolism
PLIN1Perilipin binds oleic acid on lipid dropletsLipid droplet dynamics
NR1H3Liver X receptor binds oxysterols and fatty acidsCholesterol metabolism
PPARAPeroxisome proliferator-activated receptor alpha binds fatty acidsFatty acid oxidation, inflammation

How Is oleic acid binding Regulated?

Oleic acid binding is regulated at multiple levels. The availability of oleic acid is controlled by enzymes such as SCD1, which desaturates stearic acid to oleic acid, and by dietary intake. Competitive binding by other ligands, such as warfarin and ibuprofen to serum albumin, can modulate oleic acid binding. In cancer, metabolic syndrome promotes oleic acid-mediated polyamine accumulation, suggesting that systemic metabolic status regulates oleic acid binding and downstream effects. Additionally, oleic acid treatment of rice grains alters starch digestibility through starch-lipid complex formation, indicating that binding can be influenced by the macromolecular environment.

oleic acid binding and Human Disease

GeneDisease / BiologyPotential Experimental Model
FABP4Metabolic syndrome, cancerKnockout and overexpression in cancer cell lines
ALBDrug interactions, nitro-oleic acid transportPoint mutation to alter binding affinity
SCD1Lipid metabolism, hepatosteatosisKnockout in hepatocytes
PPARGInsulin resistance, adipogenesisKnock-in of human variants
CD36Atherosclerosis, lipid uptakeOverexpression in macrophages
Oleic acid binding in colorectal cancer
Integrative plasma and fecal metabolomics identify oleic acid as a functional metabolite in adenoma-colorectal cancer progression, suggesting that oleic acid binding proteins may contribute to early diagnostic biomarkers and disease mechanisms. The study highlights that oleic acid levels and its interactions are altered during cancer progression, making oleic acid binding a potential target for intervention.
Oleic acid binding in endometrial cancer and metabolic syndrome
Metabolic syndrome promotes endometrial cancer through oleic acid-mediated polyamine accumulation, linking oleic acid binding to oncogenic metabolic reprogramming. This suggests that proteins binding oleic acid may be involved in polyamine synthesis and tumor growth under metabolic syndrome conditions.
Oleic acid binding in cardiac mitochondrial dysfunction
Oleic acid ameliorates adrenaline-induced dysfunction of rat heart mitochondria by binding with adrenaline, as shown by isothermal titration calorimetry. This indicates that oleic acid binding can protect mitochondrial function and may have therapeutic implications for cardiac stress.
Oleic acid binding in hepatocyte lipid accumulation and apoptosis
Differential effects of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes demonstrate that oleic acid binding promotes lipid storage and reduces apoptosis compared to saturated fatty acids. This has implications for non-alcoholic fatty liver disease and metabolic disorders.

From oleic acid binding-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of FABP4 affect oleic acid binding and lipid accumulation?FABP4 knockout cell line
Does a point mutation in albumin alter oleic acid binding affinity?ALB point-mutation knock-in
Can overexpression of FABP5 increase oleic acid uptake?FABP5 overexpression stable line
Does oleic acid binding to adrenaline protect mitochondria?Cardiomyocyte knockout of binding partner
Is CD36 required for oleic acid-mediated signaling?CD36 knockout in macrophages
Does SCD1 knockout reduce oleic acid synthesis and binding?SCD1 knockout hepatocytes

How to Study the oleic acid binding Process

MethodWhat It MeasuresTypical Application
Isothermal titration calorimetryBinding affinity and thermodynamicsOleic acid binding to purified proteins
Fluorescence spectroscopyBinding-induced fluorescence changesCompetitive binding with drugs
LipidomicsOleic acid and lipid species quantificationCancer metabolomics
MetabolomicsGlobal metabolite profilingBiomarker discovery
CRISPR knockoutGene function lossCausal testing of binding proteins
CRISPR point mutationSpecific amino acid changesBinding site validation
CRISPR knock-inTagged or variant protein expressionLive-cell imaging of binding
OverexpressionIncreased protein levelsGain-of-function studies
Isothermal titration calorimetry (ITC)
ITC measures the heat released or absorbed during oleic acid binding to a protein, providing thermodynamic parameters such as dissociation constant (Kd) and stoichiometry. This method was used to study oleic acid binding to adrenaline and heart mitochondria.
Fluorescence spectroscopy
Fluorescence spectroscopy can detect changes in intrinsic protein fluorescence upon oleic acid binding, as shown for human serum albumin interactions with oleic acid, warfarin, and ibuprofen. This method is suitable for determining binding affinities and competitive binding.
Lipidomics and metabolomics
Lipidomics and metabolomics quantify oleic acid and its metabolites in biological samples. Integrative plasma and fecal metabolomics identified oleic acid as a functional metabolite in colorectal cancer progression. These methods can reveal changes in oleic acid availability and binding partners.
CRISPR-based functional genomics
CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes involved in oleic acid binding. For example, knocking out FABP4 or SCD1 can reveal their roles in lipid accumulation and apoptosis.

How CRISPR Can Be Used to Study GO:0070538 oleic acid binding

Knockout

CRISPR knockout of genes encoding oleic acid binding proteins, such as FABP4 or SCD1, can determine whether these proteins are required for oleic acid-mediated effects on lipid accumulation and apoptosis. Knockout models are essential for loss-of-function studies.

Point Mutation

Point mutations can be introduced into the oleic acid binding pocket of proteins like serum albumin to alter binding affinity and specificity. This approach helps map critical residues for oleic acid binding and can validate structural predictions.

Knock-in

Knock-in of tagged versions of oleic acid binding proteins, such as GFP-FABP4, enables live-cell imaging and tracking of oleic acid binding dynamics. Knock-in of disease-associated variants can also model human mutations.

Overexpression

Overexpression of oleic acid binding proteins like FABP5 or CD36 can increase oleic acid uptake and reveal gain-of-function phenotypes in lipid metabolism and cancer progression.

How EDITGENE Supports oleic acid binding Research

Researchers studying oleic acid binding-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism, cancer progression, or mitochondrial function. EDITGENE provides CRISPR-based cell model services to enable precise genetic perturbations and functional validation.
Contact EDITGENE today to design your custom CRISPR model for oleic acid binding research.

Frequently Asked Questions About oleic acid binding

Oleic acid binding (GO:0070538) is a molecular function defined as binding to oleic acid, the 18-carbon monounsaturated fatty acid (9Z)-octadec-9-enoic acid.
Genes such as FABP4, FABP5, ALB, CD36, and SCD1 encode proteins that bind or regulate oleic acid.
GO:0070538 is the Gene Ontology identifier for the molecular function oleic acid binding.
Methods include isothermal titration calorimetry, fluorescence spectroscopy, lipidomics, and CRISPR-based functional genomics.
Colorectal cancer, endometrial cancer, metabolic syndrome, and cardiac mitochondrial dysfunction have been linked to oleic acid binding.
Yes, oleic acid binding differentially affects lipid accumulation and apoptosis in hepatocytes compared to palmitic acid.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of oleic acid binding proteins.
Serum albumin is a primary non-covalent binding protein for oleic acid and nitro-oleic acid, and its binding can be modulated by drugs.
Yes, odorant-binding proteins in termites bind oleic acid to trigger behavior, indicating evolutionary conservation.
Oleic acid binding to adrenaline ameliorates adrenaline-induced mitochondrial dysfunction in rat heart.

Conclusion

Oleic acid binding (GO:0070538) is a fundamental molecular function with broad implications for lipid metabolism, cancer, and cardiac physiology. Proteins such as FABP4, FABP5, and serum albumin mediate these interactions, which can be studied using biophysical, omics, and CRISPR-based methods. Understanding oleic acid binding provides insights into disease mechanisms and potential therapeutic targets. EDITGENE offers comprehensive CRISPR services to accelerate research in this field.

References

  1. 1. Sun Y et al.. 2024. Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.. Cancer Cell 42(8):1386-1400.e8 PMID: 39137727
  2. 2. Li H et al.. 2024. Oleic acid triggers burial behavior in a termite population through an odorant binding protein.. Insect Biochem Mol Biol 167:104090 PMID: 38369269
  3. 3. Ricchi M et al.. 2009. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.. J Gastroenterol Hepatol 24(5):830-40 PMID: 19207680
  4. 4. Zhai L et al.. 2025. Metabolic syndrome promotes endometrial cancer by Oleic acid-mediated polyamine accumulation.. Nat Commun 17(1):388 PMID: 41402312
  5. 5. Gao Q et al.. 2024. Oleic acid treatment of rice grains reduces the starch digestibility: Formation, binding state and fine structure of starch-lipid complexes.. Food Chem 457:140191 PMID: 38924913
  6. 6. Guzzi R et al.. 2022. Interactive multiple binding of oleic acid, warfarin and ibuprofen with human serum albumin revealed by thermal and fluorescence studies.. Eur Biophys J 51(1):41-49 PMID: 35048131
  7. 7. Hernychova L et al.. 2022. Serum albumin as a primary non-covalent binding protein for nitro-oleic acid.. Int J Biol Macromol 203:116-129 PMID: 35063491
  8. 8. Mishra S et al.. 2019. Oleic acid ameliorates adrenaline induced dysfunction of rat heart mitochondria by binding with adrenaline: An isothermal titration calorimetry study.. Life Sci 218:96-111 PMID: 30580019
Contact Us
*
*
*
*
How did you hear about us: